AAAAAA

   
Results: 1-18 |
Results: 18
Recent developments in chemotherapy for bladder cancer
Authors: Vaughn, DJ Malkowicz, SB
Citation: Dj. Vaughn et Sb. Malkowicz, Recent developments in chemotherapy for bladder cancer, ONCOLOGY-NY, 15(6), 2001, pp. 763
Recent advances in bladder cancer chemotherapy
Authors: Vaughn, DJ Malkowicz, SB
Citation: Dj. Vaughn et Sb. Malkowicz, Recent advances in bladder cancer chemotherapy, CANCER INV, 19(1), 2001, pp. 77-85
Phase II trial of toremifene in androgen-independent prostate cancer - A Penn cancer clinical trials group trial
Authors: Stein, S Zoltick, B Peacock, T Holroyde, C Haller, D Armstead, B Malkowicz, SB Vaughn, DJ
Citation: S. Stein et al., Phase II trial of toremifene in androgen-independent prostate cancer - A Penn cancer clinical trials group trial, AM J CL ONC, 24(3), 2001, pp. 283-285
Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia
Authors: Malkowicz, SB McKenna, WG Vaughn, DJ Wan, XS Propert, KJ Rockwell, K Marks, SHF Wein, AJ Kennedy, AR
Citation: Sb. Malkowicz et al., Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia, PROSTATE, 48(1), 2001, pp. 16-28
Inflammatory bowel disease is not associated with an increased risk of lymphoma
Authors: Lewis, JD Bilker, WB Brensinger, C Deren, JJ Vaughn, DJ Strom, BL
Citation: Jd. Lewis et al., Inflammatory bowel disease is not associated with an increased risk of lymphoma, GASTROENTY, 121(5), 2001, pp. 1080-1087
Paclitaxel and carboplatin in bladder cancer: recent developments
Authors: Vaughn, DJ
Citation: Dj. Vaughn, Paclitaxel and carboplatin in bladder cancer: recent developments, EUR J CANC, 36, 2000, pp. S7-S12
Eastern Cooperative Oncology Group phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapyin patients with locally advanced pancreas cancer: A regimen with unexpected early toxicity
Authors: Talamonti, MS Catalano, PJ Vaughn, DJ Whittington, R Beauchamp, RD Berlin, J Benson, AB
Citation: Ms. Talamonti et al., Eastern Cooperative Oncology Group phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapyin patients with locally advanced pancreas cancer: A regimen with unexpected early toxicity, J CL ONCOL, 18(19), 2000, pp. 3384-3389
Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas
Authors: Lee, JH Whittington, R Williams, NN Berry, MF Vaughn, DJ Haller, DG Rosato, EF
Citation: Jh. Lee et al., Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas, INT J RAD O, 47(4), 2000, pp. 945-953
A phase II trial of 5-fluorouracil, leucovorin, and interferon alpha 2A (IFN-alpha 2a) in metastatic pancreatic carcinoma - A Penn Cancer Clinical Trials Group (PCCTG) trial
Authors: David, AK Vaughn, DJ Holroyde, CP Armstead, B Haller, DG
Citation: Ak. David et al., A phase II trial of 5-fluorouracil, leucovorin, and interferon alpha 2A (IFN-alpha 2a) in metastatic pancreatic carcinoma - A Penn Cancer Clinical Trials Group (PCCTG) trial, AM J CL ONC, 23(1), 2000, pp. 37-39
A phase II pilot study of KW-2189 in patients with advanced renal cell carcinoma
Authors: Small, EJ Figlin, R Petrylak, D Vaughn, DJ Sartor, O Horak, I Pincus, R Kremer, A Bowden, C
Citation: Ej. Small et al., A phase II pilot study of KW-2189 in patients with advanced renal cell carcinoma, INV NEW DR, 18(2), 2000, pp. 193-197
A phase II study of gemcitabine and 5-fluorouracil in metastatic pancreatic cancer: An Eastern Cooperative Oncology Group Study (E3296)
Authors: Berlin, JD Adak, S Vaughn, DJ Flinker, D Blaszkowsky, L Harris, JE Benson, AB
Citation: Jd. Berlin et al., A phase II study of gemcitabine and 5-fluorouracil in metastatic pancreatic cancer: An Eastern Cooperative Oncology Group Study (E3296), ONCOL-BASEL, 58(3), 2000, pp. 215-218
Hormonal therapy for advanced prostate cancer
Authors: Vaughn, DJ
Citation: Dj. Vaughn, Hormonal therapy for advanced prostate cancer, ANN INT MED, 132(7), 2000, pp. 584-585
Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem cell transplantation
Authors: Tsai, DE Moore, HCF Hardy, CL Porter, DL Loh, EY Vaughn, DJ Luger, S Schuster, SJ Stadtmauer, EA
Citation: De. Tsai et al., Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem cell transplantation, BONE MAR TR, 24(5), 1999, pp. 521-526
Review and outlook for the role of paclitaxel in urothelial carcinoma
Authors: Vaughn, DJ
Citation: Dj. Vaughn, Review and outlook for the role of paclitaxel in urothelial carcinoma, SEMIN ONCOL, 26(1), 1999, pp. 117-122
Esophagus and proximal gastric tumors
Authors: Williams, NN Vaughn, DJ Whittington, R Kochman, ML Rosato, EF
Citation: Nn. Williams et al., Esophagus and proximal gastric tumors, BAS CLIN ON, 20, 1999, pp. 49-81
Carcinoid tumors
Authors: Callans, LS Vaughn, DJ Hsi, RA Glatstein, E Haynes, BE
Citation: Ls. Callans et al., Carcinoid tumors, BAS CLIN ON, 20, 1999, pp. 345-359
Combined radiation and chemotherapy in posttransplant lymphoproliferative disorder
Authors: Tsai, DE Stadtmauer, EA Canaday, DJ Vaughn, DJ
Citation: De. Tsai et al., Combined radiation and chemotherapy in posttransplant lymphoproliferative disorder, MED ONCOL, 15(4), 1998, pp. 279-281
A phase II trial and pharmacokinetic analysis of 96-hour infusional paclitaxel in patients with metastatic colorectal cancer
Authors: Huang, K Vaughn, DJ Shaw, LM Recio, A Bonner, HS Haller, DG
Citation: K. Huang et al., A phase II trial and pharmacokinetic analysis of 96-hour infusional paclitaxel in patients with metastatic colorectal cancer, AM J CL ONC, 21(6), 1998, pp. 548-552
Risultati: 1-18 |